Immediate Impact
32 standout
Citing Papers
Potential Clinical and Economic Impacts of Cutbacks in the President’s Emergency Plan for AIDS Relief Program in South Africa
2025 Standout
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
2023 Standout
Works of Ruth Soto-Malave being referenced
Efficacy and safety of Glecaprevir/Pibrentasvir in patients co-infected with hepatitis C virus and human immunodeficiency virus-1: the EXPEDITION-2 Study
2017
Examination of Noninferiority, Safety, and Tolerability of Lopinavir/ritonavir and Raltegravir Compared with Lopinavir/ritonavir and Tenofovir/ Emtricitabine in Antiretroviral-Naïve Subjects: The PROGRESS Study, 48-Week Results
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ruth Soto-Malave | 163 | 118 | 32 | 77 | 5 | 186 | |
| Anita Scribner | 199 | 150 | 46 | 60 | 7 | 235 | |
| Anthony Scarsella | 124 | 96 | 32 | 40 | 7 | 149 | |
| Cédrick Wallet | 177 | 157 | 46 | 102 | 9 | 238 | |
| W El-Sadr | 126 | 69 | 68 | 94 | 5 | 183 | |
| Concepción Cepeda | 227 | 155 | 29 | 88 | 5 | 252 | |
| Carlos Fernando de Oliveira | 240 | 196 | 51 | 56 | 6 | 261 | |
| S Dufresne | 230 | 138 | 65 | 58 | 8 | 261 | |
| Pedro Cahn | 151 | 125 | 15 | 35 | 5 | 164 | |
| Adriana Durán | 177 | 136 | 31 | 46 | 10 | 205 | |
| Mar Gutiérrez | 149 | 164 | 42 | 111 | 9 | 282 |
All Works
Loading papers...